Skip to main content
Earnings Labs
Taysha Gene Therapies, Inc. logo

Taysha Gene Therapies, Inc. (TSHA) Earnings

NASDAQ·Healthcare·Biotechnology

$4.26

+6.23%

Mkt Cap $1.29B

EPS — Estimate vs Actual

Mkt Cap

$1.29B

P/E

—

Fwd P/E

—

P/S

172.19

Rev TTM

—

EPS TTM

-$0.38